Impact of Medicare Part D on out-of-pocket drug costs and utilization for patients with cancer.

被引：1
|
作者：
Kircher, Sheetal Mehta
Johansen, Michael
Davis, Matthew M.
机构：
[1] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA
[2] Ohio State Univ, Columbus, OH 43210 USA
[3] Univ Michigan Hlth Syst, Ann Arbor, MI USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 31期
关键词：
D O I：
10.1200/jco.2013.31.31_suppl.275
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
275
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Estimating the Impact of the Inflation Reduction Act on the Out-of-Pocket Costs for Medicare Beneficiaries With Advanced Prostate Cancer
    Cortese, Brian D.
    Dusetzina, Stacie B.
    Al Awamlh, Bashir Al Hussein
    Penson, David F.
    Chang, Sam S.
    Barocas, Daniel A.
    Luckenbaugh, Amy N.
    Scarpato, Kristen R.
    Moses, Kelvin A.
    Talwar, Ruchika
    UROLOGY PRACTICE, 2023, 10 (05) : 476 - 483
  • [42] Minimizing out-of-pocket prescription drug costs for Medicare beneficiaries: Not just 'a drop in the bucket'
    Patel, Rajul A.
    Vo, Kim-Anh
    Chu, Tiffany
    Wang, Kenneth
    Lu, Shu
    Woelfel, Joseph A.
    Carr-Lopez, Sian M.
    Galal, Suzanne M.
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2014, 54 (06) : 604 - 609
  • [43] Out-of-pocket (OOP) health care expenditure burden for Medicare beneficiaries with cancer.
    Zuckerman, Ilene H.
    Pandya, Naimish B.
    Stuart, Bruce C.
    Shaffer, Thomas
    Erten, Mujde Z.
    Ke, Xuehua
    Shoemaker, J. Samantha
    Tai, Ming-Hui
    Davidoff, Amy J.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [44] The Inflation Reduction Act and Out-of-Pocket Drug Costs for Medicare Beneficiaries With Cardiovascular Disease
    Kazi, Dhruv S.
    DeJong, Colette
    Chen, Randi
    Wadhera, Rishi K.
    Tseng, Chien-Wen
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (21) : 2103 - 2111
  • [45] INFLATION REDUCTION ACT (IRA) IMPACT: MEDICARE PART D BENEFICIARIES OUT-OF-POCKET SPENDING ON INSULIN
    Varghese, I
    Liu, Z.
    Kardel, P.
    Sheetz, C.
    VALUE IN HEALTH, 2023, 26 (06) : S235 - S235
  • [46] The impact of Medicare new drug benefit (part D) on the utilization of psychotropic medications and consequent out of pocket expenditure for elderly
    Chen, H.
    Nwangwu, A.
    Aparasu, R.
    Sun, S. X.
    Lee, K. Y.
    VALUE IN HEALTH, 2008, 11 (03) : A13 - A13
  • [47] ARE OUT-OF-POCKET COSTS UNDER MEDICARE A DETERRENT TO SCREENING COLONOSCOPY?
    Li, Joy
    Cooper, Gregory S.
    GASTROENTEROLOGY, 2019, 156 (06) : S947 - S947
  • [48] Assessment of Out-of-Pocket Costs With Rebate Pass-through for Brand-name Cancer Drugs Under Medicare Part D
    Hwang, Thomas J.
    Qin, Xuanzi
    Keating, Nancy L.
    Huskamp, Haiden A.
    Dusetzina, Stacie B.
    JAMA ONCOLOGY, 2022, 8 (01) : 155 - 156
  • [49] IMPACT OF THE AFFORDABLE CARE ACT ON OUT-OF-POCKET COSTS AND UTILIZATION OF PRESCRIPTION CONTRACEPTIVES
    Becker, Nora V.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2017, 32 : S219 - S219
  • [50] ESTIMATING THE DIFFERENCE IN ANNUAL OUT-OF-POCKET COSTS FOR RELUGOLIX AND LEUPROLIDE FOR MEDICARE PATIENTS WITH METASTATIC PROSTATE CANCER
    Borrelli, E.
    McGladrigan, C. G.
    VALUE IN HEALTH, 2021, 24 : S34 - S34
12345